Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cessation vs Continuation of NAs in Chronic Hepatitis B
NCT03792919Phase 4Recruiting
- Sponsor
- Humanity & Health Medical Group
- Start
- Dec 2018
- Primary completion
- Dec 2025
- Countries
- 1
01
Overview
Phase 4, open-label trial in Chronic Hepatitis B (CHB) (2 arms), sponsored by Humanity & Health Medical Group. Primary endpoint: Incidence of HBsAg clearance at 5 years. Started Dec 2018; status: recruiting.
02
Conditions
Chronic Hepatitis B (CHB)
Beyond the preview
Go deeper on NCT03792919.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03792919.